Mechanisms regulating the menstrual cycle in women were reviewed by Vande Wiele et al. in a 1970 study published in Recent Progress in Hormone Research.
Matrix metalloproteinases and their tissue inhibitors show dynamic expression of mRNAs and proteins in the primate corpus luteum during the menstrual cycle, as reported in a 2002 study in Molecular Human Reproduction.
A secondary rise in estrogen levels occurs during the mid-luteal phase of the menstrual cycle, followed by a decrease at the end of the cycle.
Folliculogenesis begins during the last few days of the preceding menstrual cycle and continues until the release of the mature follicle at ovulation.
In a classical 28-day menstrual cycle, ovulation occurs on day 14.
During the last few days of the menstrual cycle, declining steroid production by the corpus luteum and a dramatic fall of inhibin A allow follicle stimulating hormone (FSH) levels to rise.
Patients who experience menstrual cycles at intervals of less than 21 days are termed polymenorrheic, while patients who experience prolonged menstrual cycles greater than 35 days are termed oligomenorrheic.
Administration of follicular fluid at the onset of the menstrual cycle induces luteal phase defects in rhesus monkeys, according to a 1980 study by Stouffer and Hodgen published in the Journal of Clinical Endocrinology & Metabolism.
In a classical 28-day menstrual cycle, ovulation occurs on day 14.
In the human ovary, LH receptors are located on theca cells during all stages of the menstrual cycle, whereas they are not present on granulosa cells.
On cycle day 25 of the menstrual cycle, the predecidua begins to differentiate under the surface epithelium.
Menstruation begins on cycle day 28 of the menstrual cycle.
Researchers describe a higher vulnerability for drug abuse in women during phases of the menstrual cycle when estradiol levels are high.
The elevation of FSH in the late luteal phase allows for the recruitment of a cohort of ovarian follicles in each ovary, one of which is destined to ovulate during the next menstrual cycle.
During the early follicular phase of the menstrual cycle, Luteinizing hormone (LH) secretion occurs at a pulse frequency of 60 to 90 minutes with relatively constant pulse amplitude.
By cycle day 19 of the menstrual cycle, endometrial cell pseudostratification and vacuolation disappear, and intraluminal secretions become present.
Estrogen levels rise and fall twice during the menstrual cycle.
The variability in total menstrual cycle length is usually derived from varying lengths of the follicular phase, which can range from 10 to 16 days.
On cycle day 24 of the menstrual cycle, predecidual cells appear around the spiral arterioles and stromal mitoses become more apparent.
Ovarian vein studies confirm that the corpus luteum is the site of steroid production during the luteal phase of the menstrual cycle.
Researchers describe a higher vulnerability for drug abuse in women during phases of the menstrual cycle when estradiol levels are high.
On cycle day 27 of the menstrual cycle, there is a marked lymphocytic infiltration and the upper endometrial stroma appears as a solid sheet of well-developed decidua-like cells.
Serum androstenedione and testosterone levels fluctuate during the menstrual cycle, as documented in a 1973 study in the Journal of Clinical Endocrinology & Metabolism.
The recruitment stage of the dominant follicle occurs during days 1 through 4 of the menstrual cycle.
On cycle day 21 or 22 of the menstrual cycle, the endometrial stroma begins to become edematous.
Luteinizing hormone (LH) levels are low during the early follicular phase of the menstrual cycle and begin to rise by the mid-follicular phase due to positive feedback from rising estrogen levels.
The role of luteotropic factors such as prolactin, oxytocin, inhibin, and relaxin in the menstrual cycle is unclear.
Androgens, glucocorticoids, and pituitary hormones (excluding LH and FSH) exhibit only minimal fluctuation during the normal menstrual cycle.
Plasma concentrations of 11-deoxycorticosterone fluctuate in women during the menstrual cycle, as reported in a 1981 study in Obstetrics & Gynecology.
Estrogen and progesterone receptors are present in the human ovary throughout the menstrual cycle, as determined by immunohistochemical localization in a 1990 study by Iwai et al. published in Virchows Archiv A.
Thierry van Dessel H.J. et al. published a study in 1996 in the journal J Clin Endocrinol Metab titled 'Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle', which measures growth factor levels across the menstrual cycle.
Human uterine estrogen and progesterone receptors undergo immunohistochemical changes throughout the menstrual cycle, as documented in a 1988 study in the Journal of Clinical Endocrinology & Metabolism.
Turksoy R.N. and Safaii H.S. published a paper titled 'Immediate effect of prostaglandin F2alpha during the luteal phase of the menstrual cycle' in the journal Fertility and Sterility in 1975.
During the last few days of the menstrual cycle, follicle stimulating hormone (FSH) levels rise due to declining steroid production by the corpus luteum and a dramatic fall in inhibin A levels.
Estrogen levels rise during the mid-follicular phase of the menstrual cycle and drop precipitously after ovulation.
Gonadotropins are secreted in a pulsatile fashion from the anterior pituitary, with pulse frequency and amplitude varying according to the phase of the menstrual cycle.
Najmabadi S., Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, and Stanford JB published a study titled 'Characteristics of menstrual cycles with or without intercourse in women with no known subfertility' in Human Reproduction Open in 2022.
Luteinizing hormone (LH) receptors are located on theca cells during all stages of the menstrual cycle.
On cycle day 23 of the menstrual cycle, stromal cells surrounding the spiral arterioles begin to enlarge and stromal mitoses become apparent.
Sherman B.M., West J.H., and Korenman S.G. published a 1976 study in the Journal of Clinical Endocrinology and Metabolism analyzing LH, FSH, estradiol, and progesterone concentrations during the menstrual cycles of older women.
Plasma ACTH, hGH, and cortisol levels follow specific patterns during the menstrual cycle, according to a 1975 study in the Journal of Clinical Endocrinology & Metabolism.
Gonadotropins are secreted in a pulsatile fashion from the anterior pituitary, with the frequency and amplitude of these pulses varying according to the phase of the menstrual cycle.